
	Where results make sense

Topic: Hoechst AG

	Hoechst AG - Complaint
		Respondent Hoechst is a corporation organized, existing and doing business under and by virtue of the laws of Germany, with its office and principal place of business located at D-65926 Frankfurt am Main, Germany.
		Hoechst is engaged in the discovery, development, manufacture and sale of chemicals, proprietary and generic human pharmaceutical products, and animal health products.
		Both Hoechst and RP are either in or near clinical development for the treatment of other blood clotting diseases.
	www.ftc.gov /os/1999/12/hoechstcmp.htm (1146 words)

	Hoechst AG Information
		Hoechst AG was a German life-sciences company that became Aventis after its merger with Rhône-Poulenc S.A. in 1999.
		Hoechst had been a part of the German industrial conglomerate IG Farben, which had a slave labour chemical complex beside the death camp Auschwitz during World War II.
		In 2000 the foundation was renamed the Aventis Foundation subsequent to the 1999 merger of Hoechst and Rhône-Poulenc.
	www.bookrags.com /wiki/Hoechst_AG (454 words)

	Hoechst AG in the McSpotlight
		Hoechst is the largest manufacturer of dipyrone and introduced it in 1992.
		Hoechst relented and agreed to phase out their use by 1994 but replaced them with hydrocarbons which also destroy the ozone layer.
		Hoechst was reported in 1990 to be testing CFC substitutes on animals.
	www.mcspotlight.org /beyond/companies/hoescht.html (0 words)

	Bayer, Hoechst AG, IG Farben and Nazi Germany [and Abortions ]
		Hoechst AG a company with deep roots in the Nazi party intends to control the population of the world and eliminate the lesser races as Hitler intended through the use of RU 486 and the World Health Organization.
		Hoechst AG Officials argued that the U.S. political climate is not conductive to U.S. distribution because the current administration had banned the importation of the drug and as the current views of the administration on abortion, distribution was not possible.
		Hoechst AG intends to get RU 486 approved for manufacturing and distribution in America and other countries worldwide so that they can use it to achieve goals further down the road.
	www.cephas-library.com /health/health_progesterone_abortions.html (3050 words)

	Bayer, Hoechst AG, IG Farben and Nazi Germany
		Hoechst AG a company with deep roots in the Nazi party intends to control the population of the world and eliminate the lesser races as Hitler intended through the use of RU 486 and the World Health Organization.
		Hoechst is one of the largest groups in the chemical industry, with sales of approximately US$ 13158 in DM billions for the first quarter of 1997.
		1) Hoechst AG Officials argued that the U.S. political climate is not conductive to U.S. distribution because the current administration had banned the importation of the drug and as the current views of the administration on abortion, distribution was not possible.
	www.thegreatboycott.net /nazi.html (0 words)

	Hoechst: The toxic brewmasters
		Hoechst is one of the leading producers of polymers, especially high density polyethylene, with plants in Europe, the United States, Australia and (through a joint venture with Lucky-Goldstar) South Korea.
		Hoechst justifies its position by claiming that the company does not want to get embroiled in public controversy in countries like the United States where there is significant opposition to abortion.
		Hoechst may no longer be identified in the public mind with concentration camps, but it still has a long way to go before it can be deemed a model corporate citizen.
	multinationalmonitor.org /hyper/issues/1992/05/mm0592_11.html (2072 words)

	German Law Cases
		Hoechst produces fully halogenated chlorofluorcarbons (CFCs), which apparently contribute significantly to reduction of the ozone layer and global warming.
		In May 1990 Hoechst AG and Kali Chemie AG agreed with the Federal Minister for the Environment, Nature Protection and Reactor Safety to reduce production of these CFCs by at least 30% in 1991, 50% in 1993, and entirely in 1995.
		The reply to the appeal in law unsuccessfully claims that the totality of the statement in the text and picture in the poster proves to be an assertion of facts which, being untrue, was not protected by Art 5 para 1 of the Basic Law.
	www.utexas.edu /law/academics/centers/transnational/work/german-cases/cases_bundes.shtml?12oct1993 (2523 words)

	Bayer, Hoechst AG, IG Farben and Nazi Germany [and Abortions ]
		Hoechst AG a company with deep roots in the Nazi party intends to control the population of the world and eliminate the lesser races as Hitler intended through the use of RU 486 and the World Health Organization.
		Hoechst is one of the largest groups in the chemical industry, with sales of approximately US$ 13158 in DM billions for the first quarter of 1997.
		Hoechst AG Officials argued that the U.S. political climate is not conductive to U.S. distribution because the current administration had banned the importation of the drug and as the current views of the administration on abortion, distribution was not possible.
	www.cephasministry.com /health_progesterone_abortions.html (3050 words)

	Hoechst AG
		Hoechst AG is a German firm operating in the United States through its wholly-owned subsidiaries, Hoechst Corporation and Hoechst-Roussel Pharmaceuticals, Inc., both of which are based in Somerville, New Jersey.
		Under the proposed consent agreement Hoechst has entered into, announced today for public comment, Hoechst would be required to provide Biovail with a letter of access to the toxicology data necessary to secure additional FDA approvals for Tiazac.
		The settlement would also require Hoechst to prevent the deterioration of the assets involved and maintain its research and development efforts at planned levels pending divestiture, and to provide technical assistance and advice to the purchasers in obtaining FDA approval.
	www.ftc.gov /opa/1995/09/mdh.shtm (0 words)

	Hoechst Marion Roussel Committed to Education Regarding Seldane Usage (Site not responding. Last check: 2007-10-29)
		Hoechst Marion Roussel is surprised by the continuing media attention to this issue.
		The fact is, Hoechst Marion Roussel is encouraged that our ongoing efforts to educate patients and health care professionals about this issue have resulted in a dramatic decrease (84 percent, as noted in the JAMA article) in the rates of same-day dispensing and overlapping use of Seldane and contraindicated prescription medications.
		Hoechst Marion Roussel continues to be concerned that no patient be put at risk, and maintains its commitment to all patients and health care providers by conducting ongoing initiatives to ensure that all of our products are prescribed and used appropriately.
	www.pslgroup.com /dg/800a.htm (574 words)

	Hoechst AG Beschreibung in Library - Definition und Buch-Tipp.
		Hoechst AG Informationen zum Artikel über Hoechst AG.
		Sollte eine Definition von Hoechst AG fehlen, kann diese von Ihnen verfaßt werden.
		Eine Übersicht der Artikel, die mit dem Thema Hoechst AG verwandt sind finden Sie auf der Seite alle Artikel über Hoechst AG.
	hoechst_ag.know-library.net (0 words)

	Industrial Park: Tradition and future
		The Hoechst Jahrhunderthalle conference center is a powerful cultural force in Western Frankfurt for decades to come.
		G 830 - the main laboratory - is the first complex to be finished in the new research center in the south part of the Park.
		Establishment of Farbwerke Hoechst AG, formerly known as Meister Lucius and Brüning.
	www.industriepark-hoechst.com /en/index/industriepark/tradition-zukunft.htm (1993 words)

	Alt Hoechst - Frankfurt am Main
		In 1803, Hoechst passed from the rule of Mainz to Nassau, and in 1866 became a Prussian possession.
		In 1863, Lucius, Meister and Mueller founded a factory to manufacture aniline dyes that would later become the Farbwerke Hoechst (Hoechst AG), the most important of the chemical enterprises for which the town is famous.
		Hoechst then grew so rapidly that soon almost no more free land was available for residential development.
	altfrankfurt.com /Stadtteil/Hoechst (855 words)

	PANNA: PANUPS: Hoechst Files Law Suit. June 22, 1993. PANNA.
		Hoechst successfully blocked the Philippine government from enforcing this ban, and endosulfan-containing pesticides such as Thiodan remain on the market throughout the country.
		Attorneys for Hoechst have also threatened legal action against Philippine News and Features for their recent reporting of allegations of harassment of a farmer and grassroots activist.
		At a regional congress of Philippine women farmers held in May, Abongan reiterated her experience of chronic symptoms, which persisted for years Brestan was withdrawn from the market in the Philippines by government action in 1990.
	www.panna.org /resources/pestis/PESTIS.burst.115.html (593 words)

	AgJournal On-line - More mergers
		Rhône-Poulenc S.A. and Hoechst AG announced May 17, 1999, an accelerated timetable for full merger of both companies into one life-sciences company, Aventis, by November 1999.
		Hoechst and Rhône-Poulenc plan to submit this project to extraordinary shareholder meetings in mid-July 1999.
		The shares of Celanese AG, a publicly quoted company, will be distributed to Hoechst's shareholders in a ratio of 1 for 10.
	www.countryroads.net /agjournal/story.cfm?story_id=261 (517 words)

	Rhone-Poulenc and Hoechst Agree to Accelerated Full Merger with New Timetable
		Hoechst and Rhone-Poulenc plan to submit this project to extraordinary shareholder meetings in mid-July 1999.
		Assuming Hoechst's repurchase of 29 million shares prior to the exchange offer and a 100% acceptance rate, the pro-forma ownership of Aventis would be 47% and 53% for Rhone-Poulenc and Hoechst shareholders respectively.
		Hoechst: Extraordinary Shareholders' Meeting to approve both the demerger of Celanese AG and the planned Aventis transaction.
	www.prnewswire.com /cgi-bin/stories.pl?ACCT=104&STORY=/www/story/06-17-1999/0000965798&EDATE= (1040 words)

	The Boycott-Board : Hoechst. (Site not responding. Last check: 2007-10-29)
		Bayer and Hoechst were original members of the Nazi IG Farben cartel.
		Hoechst AG pled guilty and agreed to pay a $36 million criminal fine for participating in a 17-year international conspiracy to fix prices and allocate market shares on the sale of sorbates in the United States and elsewhere.
		Federal officials charged Hoechst AG and Bernd Romahn, former Marketing Manager of Hoechst's Food Ingredients Business Unit, with conspiring with unnamed sorbates producers to suppress and eliminate competition in the sorbates industry from 1979 until 1996.
	boycot.port5.com /foodendrug/fooddoc/Hoechst.htm (737 words)

	InternationalReports.net : Germany/Hesse 2003
		In the 1990s, however, Hoechst AG disappeared in a flurry of divestments, spinoffs and mergers, leaving the sprawling redbrick complex in western Frankfurt in need of a new tenant.
		Enter Infraserv Hoechst, a closely held spinoff of Hoechst with the mission to redevelop the factory works as an industrial park – at the time an innovative concept that is now being copied by other European factory sites.
		The Hoechst veteran points out that corporate taxes, which have been reduced, are still higher than in some other countries, but allowances for accelerated depreciation can cut down the tax bill.
	www.internationalreports.net /europe/germany/hesse/2003/infraserv.html (864 words)

	LifeSite Special Report - Media Silent On Ru-486's Nazi Death Camp Pedigree
		The chiefs at Hoechst AG, now one of the largest chemical companies in the world with over 145,000 employees, did not want their overseas customers to be reminded - or perhaps learn for the first time - about Hoescht's direct link to the National Socialist (Nazi) death camps of World War II.
		Hoechst itself was born of the Nuremberg War Tribunal, which disbanded its precursor, the Nazi chemical giant IG Farben.
		Farbenworks factories at Hoechst, Degesch and Leverkusen worked overtime producing toxic gases for the Third Reich, including the deadly agent Zyklon B - the very poison that was used to exterminate millions in Hitler's gas chambers.
	www.lifesite.net /ldn/2000/oct/001004a.html (401 words)

	Frankfurt am Main: Chronik von Höchst (Site not responding. Last check: 2007-10-29)
		Nach 20 Monaten Bauzeit eröffnet die Hoechst AG ihre neue Betriebskantine mit 620 Plätzen in der Kantine und 220 Plätzen der Cafeteria auf der Empore sowie die Zentralküche, in der von 70 Mitarbeitern täglich 5.000 Essen zubereitet werden können.
		Der Vorstand der Hoechst AG beschließt, das Tochterunternehmen Cassella aufzulösen. Das Management beider Firmen begründet den Einschnitt mit härterem Wettbewerb und veränderten Marktbedingungen, was vor allem der Pharma- und der Farbstoffsparte zugesetzt habe.
		In diesem vormaligen Fabrikgelände der Hoechst AG betreibt eine Vielzahl von Unternehmen, von denen viele zur Hoechst AG gehört hatten, Produktionsanlagen oder bietet Dienste an.
	www.frankfurt.de /sixcms/detail.php?id=120582&_myvars[_id_listenartikel]=120582&_myvars[_extnav_active]=4412&_myvars[_extnav_parenturl]=Stadtteile&_myvars[_nav_id]=119777&_myvars[_stadtteil]=H%C3%B6chst (4721 words)

	Hoechst plans to sell Clariant stake - Jun. 1, 1999
		Hoechst said it plans to retain a "significant residual stake" in Clariant, but in a briefing with analysts, the company's Chief Financial Officer Klaus-Jürgen Schmieder admitted that the whole stake could be put on the market.
		Hoechst is planning the secondary offering of its stake as part of its upcoming merger with Rhône-Poulenc of France to create Aventis, the world's second-largest life sciences company.
		Hoechst currently owns 6.5 million Clariant shares, which at the current market price is worth some 4.4 billion Swiss francs ($2.9 billion).
	money.cnn.com /1999/06/01/europe/hoechst (475 words)

	FMF - The Fight to make RU486 Legal
		Hoechst AG and Roussel Uclaf say they will allow the Population Council to test and manufacture RU 486.
		However, Hoechst AG continues to prohibit Roussel Uclaf from selling RU 486 to a U.S. distributor in the interim, while an American manufacturer is established and gains FDA approval.
		Hoechst AG turns over worldwide (non-U.S.) patent rights for mifepristone to Dr. Edouard Sakiz, whose new company, Exelgyn, will distribute the compound as a method of early abortion and will begin testing on the drug's other indications.
	www.feminist.org /rrights/ru486two.html (1949 words)

	Corpus Christi Online - / Hoechst, Rhone-Poulenc plan merger
		PARIS - Hoechst of Germany and France's Rhone-Poulenc are merging their pharmaceutical operations in a deal that will create an international drug giant rivaling world leaders Merck and Glaxo Wellcome.
		Hoechst and Rhone-Poulenc's combined life sciences company, to be called Aventis, will have about $20 billion in annual sales, spanning pharmaceuticals, agricultural chemicals and animal health products, the companies said Tuesday, outlining their long-rumored merger plans.
		Hoechst Group, a subsidiary of Hoechst AG, manufactures commodity chemicals and Ticona engineered plastics at its Bishop plant.
	www.caller2.com /autoconv/bizlocal98/bizlocal60.html (757 words)

	Press Release September 1, 1999 (Site not responding. Last check: 2007-10-29)
		Hoechst Marion Roussel will pay Vertex $20 million in license fees in connection with prior research.
		Hoechst Marion Roussel will also pay Vertex up to $62 million for the successful development of HMR 3480/VX-740 in rheumatoid arthritis, the first targeted indication.
		Hoechst Marion Roussel has retained the rights to develop HMR 3480/VX-740 for additional indications and Vertex will receive similar milestones for each additional indication.
	www.vpharm.com /Pressreleases99/pr90199.html (760 words)

	Hoechst Marion Roussel and Sepracor Amend Business Arrangement to Resolve All Fexofenadine Patent Issues
		Hoechst Marion Roussel has also obtained an exclusive license to various other Sepracor US patent applications related to fexofenadine.
		Hoechst Marion Roussel AG, a world leader in pharmaceutical-based health care, is dedicated to extending and enhancing human life through the discovery, development, manufacture and sale of pharmaceutical products.
		Additional information regarding risks and uncertainties is set forth in the Registration Statement on Form 20-F and other documents of Hoechst AG on file with the Securities and Exchange Commission, or Sepracor's periodic reports and other documents on file with the Securities and Exchange Commission, as appropriate.
	www.prnewswire.com /cgi-bin/stories.pl?ACCT=104&STORY=/www/story/09-01-1999/0001013181&EDATE= (576 words)

	AEGiS-PRn: Hoechst Marion Roussel Enters Gene Therapy With Cell Genesys in the Field of AIDS
		Hoechst Marion Roussel will purchase about 13 percent of Cell Genesys' outstanding common stock for $20 million and will provide up to $30 million in milestone payments and research funding.
		Hoechst Marion Roussel also brings to the collaboration know-how and results of research in modified T cells obtained at Massachusetts General Hospital (MGH), affiliated with Harvard medical school, as part of the long term program in molecular biology funded by Hoechst.
		Hoechst Marion Roussel is a member of the Hoechst Group.
	www.aegis.com /news/pr/1995/PR951013.html (888 words)

	[No title]
		Herzlich Willkommen auf der Internetseite der Hoechst GmbH
		Seit Juli 2005 hält sanofi-aventis das gesamte Grundkapital von Hoechst, nachdem der von der Hoechst Hauptversammlung beschlossene Ausschluss („Squeeze-Out“) der früheren Minderheitsaktionäre in das Handelsregister eingetragen und damit rechtswirksam wurde.
		Hoechst verfügt heute über kein eigenes operatives Geschäft. Frühere Hoechst Aktivitäten wie Landwirtschaft und industrielle Chemie wurden im Zuge der Entstehung von Aventis und der Ausrichtung auf das Arbeitsgebiet Pharma in eigenständige Unternehmen ausgegliedert oder veräußert.
	www.sanofi-aventis.de /live/de/de/layout.jsp?scat=AC603939-733B-4C0D-8AAB-0F6E3BF9B2B7 (0 words)

Try your search on: Qwika (all wikis)